tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Neogen sees FY26 revenue $820M-$840M, consensus $803M

Sees FY26 adjusted EBITDA $165M-$175M. The company said, “The Company is initiating its full-year outlook for fiscal year 2026. Revenue is anticipated to be in the range of $820 million to $840 million, primarily reflecting the expectation of continued end-market weakness. Adjusted EBITDA is expected to be $165 million to $175 million, which includes a lower level of inventory write-offs, as well as the estimated negative impact of sample collection production inefficiencies and tariffs. Capital expenditures are expected to decline significantly in fiscal year 2026 to approximately $50 million from $105 million in fiscal 2025. The Company’s outlook excludes the results of the divested Cleaners & Disinfectants business from the closing date of July 17, 2025, forward.”

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1